Sofinnova Investments, Inc. Incyte Corp Transaction History

Sofinnova Investments, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Aug 14, 2024	BUY	$56.55 - $66.59 $75.1 Million - $88.4 Million	1,327,178 New	1,327,178 $75.6 Million
Q1 2024 May 15, 2024	BUY	$56.55 - $66.59 $58.3 Million - $68.6 Million	1,030,609 Added 347.51%	1,327,178 $75.6 Million
Q4 2023 Aug 15, 2024	BUY	$52.16 - $64.19 $15.5 Million - $19 Million	296,569 New	296,569 $18.6 Million
Q4 2023 Feb 12, 2024	BUY	$52.16 - $64.19 $15.5 Million - $19 Million	296,569 New	296,569 $18.6 Million
Q3 2019 Nov 14, 2019	SELL	$72.82 - $86.52 $5.07 Million - $6.02 Million	-69,612 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$73.52 - $88.7 $1.21 Million - $1.46 Million	16,515 Added 31.1%	69,612 $5.91 Million
Q1 2019 May 15, 2019	SELL	$63.56 - $88.17 $8.61 Million - $11.9 Million	-135,400 Reduced 71.83%	53,097 $4.57 Million
Q4 2018 Feb 14, 2019	BUY	$58.5 - $69.94 $11 Million - $13.2 Million	188,497 New	188,497 $12 Million

629

198M

766K

476K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $13.6B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.